These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22826418)

  • 1. PET/CT and renal pathology: a blind spot for radiologists? Part 2--lymphoma, leukemia, and metastatic disease.
    Zukotynski K; Lewis A; O'Regan K; Jacene H; Sakellis C; Almodovar S; Israel D
    AJR Am J Roentgenol; 2012 Aug; 199(2):W168-74. PubMed ID: 22826418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/CT and renal pathology: a blind spot for radiologists? Part 1, primary pathology.
    Zukotynski K; Lewis A; O'Regan K; Jacene H; Sakellis C; Krajewski K; Israel D
    AJR Am J Roentgenol; 2012 Aug; 199(2):W163-7. PubMed ID: 22826417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDG PET in solitary metastastic/secondary tumor of the kidney: a report of three cases and a review of the relevant literature.
    Kaneta T; Hakamatsuka T; Yamada T; Takase K; Sato A; Higano S; Kinomura S; Fukuda H; Takahashi S; Yamada S
    Ann Nucl Med; 2006 Jan; 20(1):79-82. PubMed ID: 16485580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG-PET/CT in potentially advanced renal cell carcinoma: a role in treatment decisions and prognosis estimation.
    Ferda J; Ferdova E; Hora M; Hes O; Finek J; Topolcan O; Kreuzberg B
    Anticancer Res; 2013 Jun; 33(6):2665-72. PubMed ID: 23749925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of 18F-FDG PET/CT in the detection of neurolymphomatosis.
    Zhou WL; Wu HB; Weng CS; Han YJ; Wang M; Huang S; Wang QS
    Nucl Med Commun; 2014 Nov; 35(11):1107-11. PubMed ID: 25144562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET/CT evaluation of lymphoma with renal involvement: comparison with renal carcinoma.
    Ye XH; Chen LH; Wu HB; Feng J; Zhou WL; Yang RM; Bu ZB; Ding Y; Guan J; Wang QS
    South Med J; 2010 Jul; 103(7):642-9. PubMed ID: 20531045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the diagnostic performance of (18)F-FDG-PET/CT for detection and characterization of solid renal malignancies.
    Nakhoda Z; Torigian DA; Saboury B; Hofheinz F; Alavi A
    Hell J Nucl Med; 2013; 16(1):19-24. PubMed ID: 23529389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (18)F-FDG PET/CT in primary right eyelid lymphoma.
    Wang WH; Zhan FH; Li YJ; Dang CJ
    Clin Nucl Med; 2013 Apr; 38(4):280-2. PubMed ID: 23455533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
    Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET/CT: appropriate application in lymphoma.
    Wang X
    Chin Clin Oncol; 2015 Mar; 4(1):4. PubMed ID: 25841711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F-18 FDG PET/CT findings of aggressive NK-cell leukemia.
    Derlin T; Mester J; Klutmann S
    Clin Nucl Med; 2011 Oct; 36(10):932-3. PubMed ID: 21892052
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
    Basu S; Li G; Bural G; Alavi A
    Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of 2-Deoxy-2-[18F]-fluoro-d-glucose-PET/Computed Tomography in Lymphoma.
    Tirumani SH; LaCasce AS; Jacene HA
    PET Clin; 2015 Apr; 10(2):207-25. PubMed ID: 25829087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
    Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
    Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast carcinoma metastatic to renal oncocytoma detected on F-18-FDG PET/CT.
    Fox JJ; Rohan S; Pandit-Taskar N
    Clin Nucl Med; 2009 May; 34(5):294-5. PubMed ID: 19387207
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of 18F-FDG Pet/CT and CT: diagnosis performance in lymphoma patient after treatment.
    Chiewvit S; Thephamongkhol K; Ubolnuch K; Pooliam J; Phongsawat N; Chiewvit P
    J Med Assoc Thai; 2014 Jan; 97(1):85-94. PubMed ID: 24701734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET/computed tomography and lymphoma.
    Allen-Auerbach M; de Vos S; Czernin J
    Radiol Clin North Am; 2013 Sep; 51(5):833-44. PubMed ID: 24010908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.